CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company
Lite Strategy, Inc.
Sign in to watch- Ticker
- LITS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510407811
- Phone
- 858-369-7100
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- MEI Pharma, Inc., MARSHALL EDWARDS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-27 | Baltic Charles V. III Director | Sale | −11,000 | $2.21 | $24K | 13,250 |
| 2017-11-27 | Baltic Charles V. III Director | Purchase | +11,000 | $2.25 | $25K | 24,250 |
| 2017-07-06 | White Christine Anna Director | Grant or award · Option to purchase shares of common stock | +40,000 | 122,730 | ||
| 2017-07-06 | Rueckert William Dodge Director | Grant or award · Option to purchase shares of common stock | +40,000 | 122,730 | ||
| 2017-07-06 | Reynolds Thomas C Director | Grant or award · Option to purchase shares of common stock | +40,000 | 121,049 | ||
| 2017-07-06 | Glover Nicholas Director | Grant or award · Option to purchase shares of common stock | +40,000 | 118,793 | ||
| 2017-07-06 | Clemens Kevan Director | Grant or award · Option to purchase shares of common stock | +40,000 | 112,667 | ||
| 2017-07-06 | Baltic Charles V. III Director | Grant or award · Option to purchase shares of common stock | +40,000 | 122,730 | ||
| 2017-07-06 | Urso David M Sr. V.P. and General Counsel | Grant or award · Option to purchase shares of common stock | +130,000 | 537,500 | ||
| 2017-07-06 | Mass Robert D. Chief Medical Officer | Grant or award · Option to purchase shares of common stock | +135,000 | 555,556 | ||
| 2017-07-06 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Option to purchase shares of common stock | +380,000 | 1,234,166 | ||
| 2017-07-06 | Drazba Brian G. Chief Financial Officer | Grant or award · Option to purchase shares of common stock | +50,000 | 200,000 | ||
| 2017-04-03 | Drazba Brian G. Chief Financial Officer | Grant or award · Option to purchase shares of common stock | +150,000 | 150,000 | ||
| 2016-08-05 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Restricted stock units | +102,740 | 102,740 | ||
| 2016-08-05 | Mass Robert D. Chief Medical Officer | Grant or award · Restricted stock units | +51,370 | 51,370 | ||
| 2016-08-05 | Urso David M Sr. V.P. and General Counsel | Grant or award · Restricted stock units | +51,370 | 51,370 | ||
| 2016-08-05 | Zech Thomas M. Chief Financial Officer | Grant or award · Restricted stock units | +17,123 | 17,123 | ||
| 2016-07-29 | White Christine Anna Director | Grant or award · Option to purchase shares of common stock | +40,000 | 86,924 | ||
| 2016-07-29 | Urso David M Sr. V.P. and General Counsel | Grant or award · Option to purchase shares of common stock | +130,000 | 407,500 | ||
| 2016-07-29 | Rueckert William Dodge Director | Grant or award · Option to purchase shares of common stock | +40,000 | 86,924 |
Page 9 of 13 · 252 trades